Target Name: ZNF780A
NCBI ID: G284323
Review Report on ZNF780A Target / Biomarker Content of Review Report on ZNF780A Target / Biomarker
ZNF780A
Other Name(s): Zinc finger protein 780A (isoform a) | Zinc finger protein 780A (isoform b) | Zinc finger protein 780A, transcript variant 2 | Z780A_HUMAN | ZNF780A variant 2 | ZNF780 | ZNF780A variant 1 | zinc finger protein 780A | Zinc finger protein 780A, transcript variant 1 | Zinc finger protein 780A

ZNF780A: A Potential Drug Target and Biomarker

Introduction

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF780A, a ZFPI, is a protein that has been identified as a potential drug target and biomarker. In this article, we will discuss the structure, function, and potential clinical applications of ZNF780A.

Structure and Function

ZNF780A is a 21-kDa protein that consists of 218 amino acid residues. It has a characteristic ZNF-like domain, which is composed of a nucleotide-binding oligomerization (NBO) domain and a carboxy-terminal domain. The NBO domain is responsible for the protein's stability and functions as a binding site for various nucleotides. The carboxy-terminal domain is involved in the protein's stability and functions as a receptor for various signaling molecules.

ZNF780A is a nuclear protein that is expressed in various tissues, including brain, heart, and muscle. It is primarily localized to the nuclei of cells and is involved in various cellular processes, including cell growth, differentiation, and inflammation.

Expression and Function

ZNF780A has been shown to play a role in various cellular processes, including cell growth, differentiation, and inflammation. It has been shown to be involved in the regulation of cell cycle progression, cell adhesion, and the response to various signaling pathways, such as the TGF-β pathway.

In addition to its role in cellular processes, ZNF780A has also been shown to have potential as a drug target. Several studies have shown that ZNF780A can be targeted by small molecules and antibodies, and that it can interact with various signaling molecules, including TGF- 尾, NF-kappa-B, and SMAD.

Potential Clinical Applications

The potential clinical applications of ZNF780A as a drug target and biomarker are vast. One of the main potential applications is in the treatment of various diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases.

For example, ZNF780A has been shown to be involved in the regulation of cell proliferation and has been shown to interact with various signaling molecules that are involved in cancer progression. Therefore, it is a potential target for cancer therapies that aim to inhibit cell proliferation or stimulate apoptosis.

In addition to its potential use in cancer therapies, ZNF780A has also been shown to be involved in the regulation of neurodegenerative diseases. It has been shown to be involved in the regulation of neuronal differentiation and has been shown to interact with various signaling molecules that are involved in neurodegenerative disease progression. Therefore, it is a potential target for therapies aimed at treating neurodegenerative diseases.

ZNF780A has also been shown to be involved in the regulation of autoimmune diseases. It has been shown to be involved in the regulation of immune cell function and has been shown to interact with various signaling molecules that are involved in autoimmune disease progression. Therefore, it is a potential target for therapies aimed at treating autoimmune diseases.

Conclusion

In conclusion, ZNF780A is a protein that has been identified as a potential drug target and biomarker. Its structure and function have been extensively studied, and its potential clinical applications are vast. Further research is needed to fully understand the role of ZNF780A in various cellular processes and its potential as a drug target.

Protein Name: Zinc Finger Protein 780A

Functions: May be involved in transcriptional regulation

The "ZNF780A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF780A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3 | ZNHIT6 | ZNRD2 | ZNRD2-DT | ZNRF1 | ZNRF2 | ZNRF2P1 | ZNRF3 | ZNRF3-AS1 | ZNRF4 | ZP1 | ZP2 | ZP3